{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:37:40Z","timestamp":1760985460947},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11910-016-0655-4","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:08:49Z","timestamp":1460621329000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Imaging Systemic Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Per","family":"Borghammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"655_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2015.09.007","volume":"59","author":"CP Weingarten","year":"2015","unstructured":"Weingarten CP, Sundman MH, Hickey P, Chen NK. Neuroimaging of Parkinson\u2019s disease: expanding views. Neurosci Biobehav Rev. 2015;59:16\u201352. doi: 10.1016\/j.neubiorev.2015.09.007 .","journal-title":"Neurosci Biobehav Rev"},{"key":"655_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N. Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol. 2011;95:614\u201328. doi: 10.1016\/j.pneurobio.2011.08.009 .","journal-title":"Prog Neurobiol"},{"key":"655_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14737175.2014.877842","volume":"14","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA. The pathomechanisms underlying Parkinson\u2019s disease. Expert Rev Neurother. 2014;14:199\u2013215. doi: 10.1586\/14737175.2014.877842 .","journal-title":"Expert Rev Neurother"},{"key":"655_CR4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119:689\u2013702. doi: 10.1007\/s00401-010-0664-3 . The study demonstrated widespread alpha-synuclein pathology throughout the gastrointestinal canal in most PD patients, and furthermore that a distinct cranio-caudal gradient is present in the severity of pathological involvement.","journal-title":"Acta Neuropathol"},{"key":"655_CR5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29:1010\u20138. doi: 10.1002\/mds.25776 .","journal-title":"Mov Disord"},{"key":"655_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127:235\u201341. doi: 10.1007\/s00401-013-1214-6 .","journal-title":"Acta Neuropathol"},{"key":"655_CR7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord. 2012;27:716\u20139. doi: 10.1002\/mds.25020 .","journal-title":"Mov Disord"},{"key":"655_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, et al. Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology. 2001;57:456\u201362.","journal-title":"Neurology"},{"key":"655_CR9","doi-asserted-by":"crossref","unstructured":"Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2015. doi: 10.1136\/jnnp-2015-311680","DOI":"10.1136\/jnnp-2015-311680"},{"key":"655_CR10","doi-asserted-by":"crossref","unstructured":"Noyce AJ, Lees AJ, Schrag AE. The prediagnostic phase of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2016. doi: 10.1136\/jnnp-2015-311890","DOI":"10.1136\/jnnp-2015-311890"},{"key":"655_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 2016;131:49\u201373. doi: 10.1007\/s00401-015-1485-1 . This is a thoughtful and critical review of whether or not PD is characterized by predictable spreading of misfolded protein along specific anatomic pathways.","journal-title":"Acta Neuropathol"},{"key":"655_CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 2003;110:517\u201336. doi: 10.1007\/s00702-002-0808-2 .","journal-title":"J Neural Transm (Vienna)"},{"key":"655_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-015-0236-9","volume":"3","author":"H Sumikura","year":"2015","unstructured":"Sumikura H, Takao M, Hatsuta H, Ito S, Nakano Y, Uchino A, et al. Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons. Acta Neuropathol Commun. 2015;3:57. doi: 10.1186\/s40478-015-0236-9 .","journal-title":"Acta Neuropathol Commun"},{"key":"655_CR14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131:642\u201350. doi: 10.1093\/brain\/awm302 .","journal-title":"Brain"},{"key":"655_CR15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/01.CIR.81.5.1606","volume":"81","author":"DS Goldstein","year":"1990","unstructured":"Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation. 1990;81:1606\u201321.","journal-title":"Circulation"},{"key":"655_CR16","doi-asserted-by":"crossref","unstructured":"Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H. Brain imaging in Aging Special Issue of Ageing Research Reviews I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies. Ageing research reviews. 2016. doi: 10.1016\/j.arr.2016.01.001","DOI":"10.1016\/j.arr.2016.01.001"},{"key":"655_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.parkreldis.2013.11.001","volume":"20","author":"R Sakakibara","year":"2014","unstructured":"Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Terada H, Inaoka T. MIBG myocardial scintigraphy in pre-motor Parkinson\u2019s disease: a review. Parkinsonism Relat Disord. 2014;20:267\u201373. doi: 10.1016\/j.parkreldis.2013.11.001 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review. J Mov Disord. 2015;8:55\u201366. doi: 10.14802\/jmd.15015 .","journal-title":"J Mov Disord"},{"key":"655_CR19","first-page":"1099","volume":"47","author":"K Kashihara","year":"2006","unstructured":"Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies. J Nucl Med. 2006;47:1099\u2013101.","journal-title":"J Nucl Med"},{"key":"655_CR20","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","volume":"121","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Holmes C, Kopin IJ, Sharabi Y. Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest. 2011;121:3320\u201330. doi: 10.1172\/JCI45803 .","journal-title":"J Clin Invest"},{"key":"655_CR21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13139-015-0354-0","volume":"49","author":"SH Kwon","year":"2015","unstructured":"Kwon SH, Yoon JK, Yoon JH, Lee SJ, Jo KS, Lee DH, et al. The utility of segmental analysis in cardiac I-123 MIBG SPECT in Parkinson\u2019s disease. Nucl Med Mol Imaging. 2015;49:298\u2013302. doi: 10.1007\/s13139-015-0354-0 .","journal-title":"Nucl Med Mol Imaging"},{"key":"655_CR22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00702-015-1409-1","volume":"122","author":"JK Oh","year":"2015","unstructured":"Oh JK, Choi EK, Song IU, Kim JS, Chung YA. Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease. J Neural Transm (Vienna). 2015;122:1421\u20137. doi: 10.1007\/s00702-015-1409-1 .","journal-title":"J Neural Transm (Vienna)"},{"key":"655_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"655_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","volume":"19","author":"M Yoshita","year":"1998","unstructured":"Yoshita M, Hayashi M, Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease. Nucl Med Commun. 1998;19:137\u201342.","journal-title":"Nucl Med Commun"},{"key":"655_CR25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/gps.4229","volume":"30","author":"S Slaets","year":"2015","unstructured":"Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, et al. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Int J Geriatr Psychiatry. 2015;30:864\u20139. doi: 10.1002\/gps.4229 .","journal-title":"Int J Geriatr Psychiatry"},{"key":"655_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.parkreldis.2011.02.001","volume":"17","author":"F Tateno","year":"2011","unstructured":"Tateno F, Sakakibara R, Kishi M, Ogawa E, Terada H, Ogata T, et al. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord. 2011;17:395\u20137. doi: 10.1016\/j.parkreldis.2011.02.001 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res. 2012;22:43\u201355. doi: 10.1007\/s10286-011-0135-5 .","journal-title":"Clin Auton Res"},{"key":"655_CR28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18:494\u2013500. doi: 10.1016\/j.parkreldis.2012.01.009 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR29","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","volume":"67","author":"T Miyamoto","year":"2006","unstructured":"Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236\u20138. doi: 10.1212\/01.wnl.0000249313.25627.2e .","journal-title":"Neurology"},{"key":"655_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","volume":"12","author":"A Iranzo","year":"2013","unstructured":"Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12:443\u201353. doi: 10.1016\/S1474-4422(13)70056-5 . A landmark study describing conversion rate of patients with RBD.","journal-title":"Lancet Neurol"},{"key":"655_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16:252\u20135. doi: 10.1016\/j.parkreldis.2009.12.010 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","volume":"43","author":"S Shimizu","year":"2016","unstructured":"Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, et al. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2016;43:184\u201392. doi: 10.1007\/s00259-015-3146-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"655_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","volume":"220","author":"S Saiki","year":"2004","unstructured":"Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci. 2004;220:105\u201311. doi: 10.1016\/j.jns.2004.02.018 .","journal-title":"J Neurol Sci"},{"key":"655_CR34","first-page":"475854","volume":"2014","author":"SM Fereshtehnejad","year":"2014","unstructured":"Fereshtehnejad SM, Lokk J. Orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsons Dis. 2014;2014:475854. doi: 10.1155\/2014\/475854 .","journal-title":"Parkinsons Dis"},{"key":"655_CR35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology. 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"655_CR36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s002590050548","volume":"27","author":"MJ Reinhardt","year":"2000","unstructured":"Reinhardt MJ, Jungling FD, Krause TM, Braune S. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. Eur J Nucl Med. 2000;27:595\u2013600.","journal-title":"Eur J Nucl Med"},{"key":"655_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2011.08.018","volume":"18","author":"K Berganzo","year":"2012","unstructured":"Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D, et al. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord. 2012;18:45\u20138. doi: 10.1016\/j.parkreldis.2011.08.018 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1210\/endo-94-4-959","volume":"94","author":"A Melander","year":"1974","unstructured":"Melander A, Ericson LE, Sundler F, Ingbar SH. Sympathetic innervation of the mouse thyroid and its significance in thyroid hormone secretion. Endocrinology. 1974;94:959\u201366. doi: 10.1210\/endo-94-4-959 .","journal-title":"Endocrinology"},{"key":"655_CR39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology. 2002;58:1247\u201355.","journal-title":"Neurology"},{"key":"655_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02984609","volume":"19","author":"H Matsui","year":"2005","unstructured":"Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, et al. Metaiodobenzylguanidine (MIBG) uptake in Parkinson\u2019s disease also decreases at thyroid. Ann Nucl Med. 2005;19:225\u20139.","journal-title":"Ann Nucl Med"},{"key":"655_CR41","first-page":"1775","volume":"46","author":"DN Tipre","year":"2005","unstructured":"Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson\u2019s disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46:1775\u201381.","journal-title":"J Nucl Med"},{"key":"655_CR42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","volume":"77","author":"GF DiBona","year":"1997","unstructured":"DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75\u2013197.","journal-title":"Physiol Rev"},{"key":"655_CR43","doi-asserted-by":"crossref","unstructured":"Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology. 2014. doi: 10.1212\/WNL.0000000000000204","DOI":"10.1212\/WNL.0000000000000204"},{"key":"655_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2006.10.006","volume":"133","author":"GB Proctor","year":"2007","unstructured":"Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Autonomic neuroscience : basic & clinical. 2007;133:3\u201318. doi: 10.1016\/j.autneu.2006.10.006 .","journal-title":"Autonomic neuroscience : basic & clinical"},{"key":"655_CR45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"655_CR46","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1212\/WNL.42.11.2106","volume":"42","author":"WP Gai","year":"1992","unstructured":"Gai WP, Blumbergs PC, Geffen LB, Blessing WW. Age-related loss of dorsal vagal neurons in Parkinson\u2019s disease. Neurology. 1992;42:2106\u201311.","journal-title":"Neurology"},{"key":"655_CR47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/brain\/86.4.781","volume":"86","author":"MJ Eadie","year":"1963","unstructured":"Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain. 1963;86:781\u201392.","journal-title":"Brain"},{"key":"655_CR48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396:67\u201372. doi: 10.1016\/j.neulet.2005.11.012 .","journal-title":"Neurosci Lett"},{"key":"655_CR49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/ars.2014.5859","volume":"21","author":"JG Greene","year":"2014","unstructured":"Greene JG. Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson\u2019s disease. Antioxid Redox Signal. 2014;21:649\u201367. doi: 10.1089\/ars.2014.5859 .","journal-title":"Antioxid Redox Signal"},{"key":"655_CR50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol. 1988;76:217\u201321.","journal-title":"Acta Neuropathol"},{"key":"655_CR51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0079-6123(08)61859-2","volume":"107","author":"DA Hopkins","year":"1996","unstructured":"Hopkins DA, Bieger D, devente J, Steinbusch WM. Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res. 1996;107:79\u201396.","journal-title":"Prog Brain Res"},{"key":"655_CR52","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","volume":"124","author":"DM Annerino","year":"2012","unstructured":"Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson\u2019s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol. 2012;124:665\u201380. doi: 10.1007\/s00401-012-1040-2 .","journal-title":"Acta Neuropathol"},{"key":"655_CR53","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, et al. Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One. 2010;5:e12728. doi: 10.1371\/journal.pone.0012728 .","journal-title":"PLoS One"},{"key":"655_CR54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;62:436\u201346.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"655_CR55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78:522\u20139. doi: 10.1002\/ana.24448 .","journal-title":"Ann Neurol"},{"key":"655_CR56","volume-title":"Cholinesterases and cholinesterase inhibitors","author":"E Giacobini","year":"2000","unstructured":"Giacobini E. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000."},{"key":"655_CR57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000145053","volume":"104","author":"W Schmid","year":"1979","unstructured":"Schmid W, van der Zypen E, Keller H. Die Wirkung einer subtotalen Vagotomie auf den Plexus myentericus (Auerbach) verschiedener Darmabschnitte. Acta Anat (Basel). 1979;104:36\u201351.","journal-title":"Acta Anat (Basel)"},{"key":"655_CR58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.autneu.2013.01.006","volume":"176","author":"DH Pauza","year":"2013","unstructured":"Pauza DH, Saburkina I, Rysevaite K, Inokaitis H, Jokubauskas M, Jalife J, et al. Neuroanatomy of the murine cardiac conduction system: a combined stereomicroscopic and fluorescence immunohistochemical study. Auton Neurosci. 2013;176:32\u201347. doi: 10.1016\/j.autneu.2013.01.006 .","journal-title":"Auton. Neurosci"},{"key":"655_CR59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cne.10599","volume":"459","author":"M Anlauf","year":"2003","unstructured":"Anlauf M, Schafer MK, Eiden L, Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol. 2003;459:90\u2013111. doi: 10.1002\/cne.10599 .","journal-title":"J Comp Neurol"},{"key":"655_CR60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2125.2007.03063.x","volume":"65","author":"N Okamura","year":"2008","unstructured":"Okamura N, Funaki Y, Tashiro M, Kato M, Ishikawa Y, Maruyama M, et al. In vivo visualization of donepezil binding in the brain of patients with Alzheimer\u2019s disease. Br J Clin Pharmacol. 2008;65:472\u20139. doi: 10.1111\/j.1365-2125.2007.03063.x .","journal-title":"Br J Clin Pharmacol"},{"key":"655_CR61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000338774","volume":"68","author":"K Hiraoka","year":"2012","unstructured":"Hiraoka K, Okamura N, Funaki Y, Hayashi A, Tashiro M, Hisanaga K, et al. Cholinergic deficit and response to donepezil therapy in Parkinson\u2019s disease with dementia. Eur Neurol. 2012;68:137\u201343. doi: 10.1159\/000338774 .","journal-title":"Eur Neurol"},{"key":"655_CR62","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2967\/jnumed.114.143859","volume":"55","author":"T Gjerloff","year":"2014","unstructured":"Gjerloff T, Jakobsen S, Nahimi A, Munk OL, Bender D, Alstrup AK, et al. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11c-donepezil: dosimetry, biodistribution, and kinetic analyses. J Nucl Med. 2014;55:1818\u201324. doi: 10.2967\/jnumed.114.143859 .","journal-title":"J Nucl Med"},{"key":"655_CR63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awu369","volume":"138","author":"T Gjerloff","year":"2015","unstructured":"Gjerloff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, et al. Imaging acetylcholinesterase density in peripheral organs in Parkinson\u2019s disease with 11C-donepezil PET. Brain. 2015;138:653\u201363. doi: 10.1093\/brain\/awu369 . This study demonstrated that 11C-donepezil PET may be the first successful method for imaging parasympathetic denervation in peripheral organs of PD patients.","journal-title":"Brain"},{"key":"655_CR64","doi-asserted-by":"crossref","unstructured":"Roy A, Fields WC, Rocha-Resende C C, Resende RR, Guatimosim S, Prado VF, et al. Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. Faseb J. 2013. doi: 10.1096\/fj.13-238279 .","DOI":"10.1096\/fj.13-238279"},{"key":"655_CR65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2967\/jnumed.113.124792","volume":"55","author":"M Petrou","year":"2014","unstructured":"Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, et al. In vivo imaging of human cholinergic nerve terminals with (\u2212)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med. 2014;55:396\u2013404. doi: 10.2967\/jnumed.113.124792 .","journal-title":"J Nucl Med"},{"key":"655_CR66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14:625\u201339. doi: 10.1016\/S1474-4422(15)00007-1 .","journal-title":"Lancet Neurol"},{"key":"655_CR67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol Dis. 2012;46:559\u201364. doi: 10.1016\/j.nbd.2011.10.014 .","journal-title":"Neurobiol Dis"},{"key":"655_CR68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.parkreldis.2011.11.006","volume":"18","author":"JG Kalf","year":"2012","unstructured":"Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18:311\u20135. doi: 10.1016\/j.parkreldis.2011.11.006 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","volume":"17","author":"RF Pfeiffer","year":"2011","unstructured":"Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2011;17:10\u20135. doi: 10.1016\/j.parkreldis.2010.08.003 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.24006","volume":"27","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Silveira-Moriyama L, Gilpin P, Ling H, Howard R, Lees AJ. Severe dysphagia as a presentation of Parkinson\u2019s disease. Mov Disord. 2012;27:457\u20138. doi: 10.1002\/mds.24006 .","journal-title":"Mov Disord"},{"key":"655_CR71","doi-asserted-by":"crossref","unstructured":"Kikuchi A, Baba T, Hasegawa T, Kobayashi M, Sugeno N, Konno M, et al. Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson\u2019s disease: a cross-sectional and 3-year longitudinal cohort study. BMJ open. 2013;3. doi: 10.1136\/bmjopen-2012-002249","DOI":"10.1136\/bmjopen-2012-002249"},{"key":"655_CR72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/physrev.2001.81.2.929","volume":"81","author":"A Jean","year":"2001","unstructured":"Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001;81:929\u201369.","journal-title":"Physiol Rev"},{"key":"655_CR73","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, et al. Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord. 2010;25:2508\u201315. doi: 10.1002\/mds.23305 .","journal-title":"Mov Disord"},{"key":"655_CR74","unstructured":"Logemann J. Measurements of swallow from videofluoroscopic studies. 2 ed: Texas Pro-ed.; 1993."},{"key":"655_CR75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/PL00009512","volume":"12","author":"NA Leopold","year":"1997","unstructured":"Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson\u2019s disease. Dysphagia. 1997;12:11\u20138. discussion 9\u201320.","journal-title":"Dysphagia"},{"key":"655_CR76","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1212\/WNL.39.10.1309","volume":"39","author":"M Bushmann","year":"1989","unstructured":"Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson\u2019s disease. Neurology. 1989;39:1309\u201314.","journal-title":"Neurology"},{"key":"655_CR77","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.20342","volume":"20","author":"FS Monte","year":"2005","unstructured":"Monte FS, da Silva-Junior FP, Braga-Neto P, Souza MA N e, de Bruin VM. Swallowing abnormalities and dyskinesia in Parkinson\u2019s disease. Mov Disord. 2005;20:457\u201362. doi: 10.1002\/mds.20342 .","journal-title":"Mov Disord"},{"key":"655_CR78","volume-title":"Esophageal transit scintigraphy","author":"H Klein","year":"1988","unstructured":"Klein H, Wald A. Esophageal transit scintigraphy. New York: New Raven Press; 1988."},{"key":"655_CR79","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1353-8020(03)00045-2","volume":"9","author":"A Potulska","year":"2003","unstructured":"Potulska A, Friedman A, Krolicki L, Spychala A. Swallowing disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2003;9:349\u201353.","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.physiol.68.040504.094718","volume":"68","author":"KM Sanders","year":"2006","unstructured":"Sanders KM, Koh SD, Ward SM. Interstitial cells of cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol. 2006;68:307\u201343. doi: 10.1146\/annurev.physiol.68.040504.094718 .","journal-title":"Annu Rev Physiol"},{"key":"655_CR81","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","volume":"134","author":"ML Schubert","year":"2008","unstructured":"Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842\u201360. doi: 10.1053\/j.gastro.2008.05.021 .","journal-title":"Gastroenterology"},{"key":"655_CR82","first-page":"195","volume-title":"Gastroenterology","author":"WL Hasler","year":"2003","unstructured":"Hasler WL. In: Yamada T, editor. Gastroenterology. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 195\u2013219."},{"key":"655_CR83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mds.25708","volume":"29","author":"S Marrinan","year":"2014","unstructured":"Marrinan S, Emmanuel AV, Burn DJ. Delayed gastric emptying in Parkinson\u2019s disease. Mov Disord. 2014;29:23\u201332. doi: 10.1002\/mds.25708 .","journal-title":"Mov Disord"},{"key":"655_CR84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","volume":"18","author":"ZS Heetun","year":"2012","unstructured":"Heetun ZS, Quigley EM. Gastroparesis and Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2012;18:433\u201340. doi: 10.1016\/j.parkreldis.2011.12.004 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR85","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, et al. Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623\u20139. doi: 10.1002\/mds.21586 .","journal-title":"Mov Disord"},{"key":"655_CR86","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69:333\u201341. doi: 10.1212\/01.wnl.0000266593.50534.e8 .","journal-title":"Neurology"},{"key":"655_CR87","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.24993","volume":"27","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Neunlist M, Derkinderen P. Lewy pathology in gastric and duodenal biopsies in Parkinson\u2019s disease. Mov Disord. 2012;27:708. doi: 10.1002\/mds.24993 .","journal-title":"Mov Disord"},{"key":"655_CR88","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2967\/jnmt.109.067843","volume":"37","author":"KJ Donohoe","year":"2009","unstructured":"Donohoe KJ, Maurer AH, Ziessman HA, Urbain JL, Royal HD, Martin-Comin J, et al. Procedure guideline for adult solid-meal gastric-emptying study 3.0. J Nucl Med Technol. 2009;37:196\u2013200. doi: 10.2967\/jnmt.109.067843 .","journal-title":"J Nucl Med Technol"},{"key":"655_CR89","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/WNL.31.10.1288","volume":"31","author":"MA Evans","year":"1981","unstructured":"Evans MA, Broe GA, Triggs EJ, Cheung M, Creasey H, Paull PD. Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. Neurology. 1981;31:1288\u201394.","journal-title":"Neurology"},{"key":"655_CR90","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","volume":"46","author":"R Djaldetti","year":"1996","unstructured":"Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson\u2019s disease: patients with and without response fluctuations. Neurology. 1996;46:1051\u20134.","journal-title":"Neurology"},{"key":"655_CR91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.parkreldis.2009.04.003","volume":"15","author":"A Krygowska-Wajs","year":"2009","unstructured":"Krygowska-Wajs A, Cheshire Jr WP, Wszolek ZK, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, et al. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord. 2009;15:692\u20136. doi: 10.1016\/j.parkreldis.2009.04.003 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR92","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","volume":"16","author":"R Hardoff","year":"2001","unstructured":"Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, et al. Gastric emptying time and gastric motility in patients with Parkinson\u2019s disease. Mov Disord. 2001;16:1041\u20137. doi: 10.1002\/mds.1203 .","journal-title":"Mov Disord"},{"key":"655_CR93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-010-5769-z","volume":"258","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson\u2019s disease? An analysis using the 13C-acetate breath test. J Neurol. 2011;258:421\u20136. doi: 10.1007\/s00415-010-5769-z .","journal-title":"J Neurol"},{"key":"655_CR94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2004.11.007","volume":"375","author":"O Goetze","year":"2005","unstructured":"Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson\u2019s disease using 13C-sodium octanoate breath test. Neurosci Lett. 2005;375:170\u20133. doi: 10.1016\/j.neulet.2004.11.007 .","journal-title":"Neurosci Lett"},{"key":"655_CR95","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00415-015-7799-z","volume":"262","author":"L Epprecht","year":"2015","unstructured":"Epprecht L, Schreglmann SR, Goetze O, Woitalla D, Baumann CR, Waldvogel D. Unchanged gastric emptying and visceral perception in early Parkinson\u2019s disease after a high caloric test meal. J Neurol. 2015;262:1946\u201353. doi: 10.1007\/s00415-015-7799-z .","journal-title":"J Neurol"},{"key":"655_CR96","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2982.2006.00780.x","volume":"18","author":"O Goetze","year":"2006","unstructured":"Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, et al. Predictors of gastric emptying in Parkinson\u2019s disease. Neurogastroenterol Motil. 2006;18:369\u201375. doi: 10.1111\/j.1365-2982.2006.00780.x .","journal-title":"Neurogastroenterol Motil"},{"key":"655_CR97","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/mds.23933","volume":"26","author":"MM Unger","year":"2011","unstructured":"Unger MM, Moller JC, Mankel K, Schmittinger K, Eggert KM, Stamelou M, et al. Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test. Mov Disord. 2011;26:2559\u201363. doi: 10.1002\/mds.23933 .","journal-title":"Mov Disord"},{"key":"655_CR98","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/brain\/aws086","volume":"135","author":"E Arai","year":"2012","unstructured":"Arai E, Arai M, Uchiyama T, Higuchi Y, Aoyagi K, Yamanaka Y, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson\u2019s disease. Brain. 2012;135:1478\u201385. doi: 10.1093\/brain\/aws086 .","journal-title":"Brain"},{"key":"655_CR99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2012.05.010","volume":"319","author":"H Doi","year":"2012","unstructured":"Doi H, Sakakibara R, Sato M, Masaka T, Kishi M, Tateno A, et al. Plasma levodopa peak delay and impaired gastric emptying in Parkinson\u2019s disease. J Neurol Sci. 2012;319:86\u20138. doi: 10.1016\/j.jns.2012.05.010 .","journal-title":"J Neurol Sci"},{"key":"655_CR100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pgmj.72.845.164","volume":"72","author":"KN Davies","year":"1996","unstructured":"Davies KN, King D, Billington D, Barrett JA. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson\u2019s disease. Postgrad Med J. 1996;72:164\u20137.","journal-title":"Postgrad Med J"},{"key":"655_CR101","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-015-1442-0","volume":"122","author":"J Dutkiewicz","year":"2015","unstructured":"Dutkiewicz J, Szlufik S, Nieciecki M, Charzynska I, Krolicki L, Smektala P, et al. Small intestine dysfunction in Parkinson\u2019s disease. J Neural Transm (Vienna). 2015;122:1659\u201361. doi: 10.1007\/s00702-015-1442-0 .","journal-title":"J Neural Transm (Vienna)"},{"key":"655_CR102","doi-asserted-by":"crossref","first-page":"e29ee75","DOI":"10.1016\/j.parkreldis.2015.10.082","volume":"22","author":"K Knudsen","year":"2016","unstructured":"Knudsen K, Fedorova T, Borghammer P. Colonic volume and gastrointestinal symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;22:e29ee75. P 1.067.","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR103","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.parkreldis.2012.06.008","volume":"18","author":"A Damian","year":"2012","unstructured":"Damian A, Adler CH, Hentz JG, Shill HA, Caviness JN, Sabbagh MN, et al. Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18:1089\u201393. doi: 10.1016\/j.parkreldis.2012.06.008 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR104","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord. 2009;24:1641\u20139. doi: 10.1002\/mds.22643 .","journal-title":"Mov Disord"},{"key":"655_CR105","doi-asserted-by":"crossref","unstructured":"Chaudhuri KR, Odin P. The challenge of non-motor symptoms in Parkinson\u2019s disease. 2010;184:325\u201341. doi: 10.1016\/s0079-6123(10)84017-8","DOI":"10.1016\/S0079-6123(10)84017-8"},{"key":"655_CR106","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00415-011-6386-1","volume":"259","author":"Y Nihei","year":"2012","unstructured":"Nihei Y, Takahashi K, Koto A, Mihara B, Morita Y, Isozumi K, et al. REM sleep behavior disorder in Japanese patients with Parkinson\u2019s disease: a multicenter study using the REM sleep behavior disorder screening questionnaire. J Neurol. 2012;259:1606\u201312. doi: 10.1007\/s00415-011-6386-1 .","journal-title":"J Neurol"},{"key":"655_CR107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00345-004-0484-y","volume":"23","author":"G Holstege","year":"2005","unstructured":"Holstege G. Central nervous system control of ejaculation. World J Urol. 2005;23:109\u201314. doi: 10.1007\/s00345-004-0484-y .","journal-title":"World J Urol"},{"key":"655_CR108","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/nau.20193","volume":"25","author":"K Winge","year":"2006","unstructured":"Winge K, Skau AM, Stimpel H, Nielsen KK, Werdelin L. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn. 2006;25:116\u201322. doi: 10.1002\/nau.20193 .","journal-title":"Neurourol Urodyn"},{"key":"655_CR109","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Tredici Del","year":"2012","unstructured":"Del Tredici K, Braak H. Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2012;124:643\u201364. doi: 10.1007\/s00401-012-1028-y . This study demonstrated consistent, severe pathology in sacral parasympathetic nuclei of patients with manifest PD.","journal-title":"Acta Neuropathol"},{"key":"655_CR110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ana.24430","volume":"78","author":"VG VanderHorst","year":"2015","unstructured":"VanderHorst VG, Samardzic T, Saper CB, Anderson MP, Nag S, Schneider JA, et al. alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015;78:142\u20139. doi: 10.1002\/ana.24430 .","journal-title":"Ann Neurol"},{"key":"655_CR111","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/00365528809095938","volume":"152","author":"H Abrahamsson","year":"1988","unstructured":"Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients. Scand J Gastroenterol Suppl. 1988;152:72\u201380.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"655_CR112","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1111\/codi.12105","volume":"15","author":"CP Wang","year":"2013","unstructured":"Wang CP, Sung WH, Wang CC, Tsai PY. Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson\u2019s disease associated with bowel dysfunction. Colorectal Dis. 2013;15:e130\u20137. doi: 10.1111\/codi.12105 .","journal-title":"Colorectal Dis"},{"key":"655_CR113","first-page":"673","volume":"106","author":"WH Jost","year":"1994","unstructured":"Jost WH, Schimrigk K. The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson\u2019s disease. Wien Klin Wochenschr. 1994;106:673\u20136.","journal-title":"Wien Klin Wochenschr"},{"key":"655_CR114","first-page":"15","volume":"89","author":"LL Edwards","year":"1994","unstructured":"Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Characterization of swallowing and defecation in Parkinson\u2019s disease. Am J Gastroenterol. 1994;89:15\u201325.","journal-title":"Am J Gastroenterol"},{"key":"655_CR115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.74.2.268","volume":"74","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, et al. Colonic transit time and rectoanal videomanometry in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2003;74:268\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"655_CR116","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/BF01798536","volume":"69","author":"WH Jost","year":"1991","unstructured":"Jost WH, Schimrigk K. Constipation in Parkinson\u2019s disease. Klin Wochenschr. 1991;69:906\u20139.","journal-title":"Klin Wochenschr"},{"key":"655_CR117","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mds.870120617","volume":"12","author":"W Ashraf","year":"1997","unstructured":"Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM. Constipation in Parkinson\u2019s disease: objective assessment and response to psyllium. Mov Disord. 1997;12:946\u201351. doi: 10.1002\/mds.870120617 .","journal-title":"Mov Disord"},{"key":"655_CR118","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.parkreldis.2011.06.002","volume":"17","author":"F Tateno","year":"2011","unstructured":"Tateno F, Sakakibara R, Yokoi Y, Kishi M, Ogawa E, Uchiyama T, et al. Levodopa ameliorated anorectal constipation in de novo Parkinson\u2019s disease: the QL-GAT study. Parkinsonism Relat Disord. 2011;17:662\u20136. doi: 10.1016\/j.parkreldis.2011.06.002 .","journal-title":"Parkinsonism Relat Disord"},{"key":"655_CR119","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/mds.20387","volume":"20","author":"Z Liu","year":"2005","unstructured":"Liu Z, Sakakibara R, Odaka T, Uchiyama T, Uchiyama T, Yamamoto T, et al. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord. 2005;20:680\u20136. doi: 10.1002\/mds.20387 .","journal-title":"Mov Disord"},{"key":"655_CR120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2007-977489","volume":"20","author":"SR Steele","year":"2007","unstructured":"Steele SR, Mellgren A. Constipation and obstructed defecation. Clin Colon Rectal Surg. 2007;20:110\u20137. doi: 10.1055\/s-2007-977489 .","journal-title":"Clin Colon Rectal Surg"},{"key":"655_CR121","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/jnnp.51.12.1503","volume":"51","author":"SE Mathers","year":"1988","unstructured":"Mathers SE, Kempster PA, Swash M, Lees AJ. Constipation and paradoxical puborectalis contraction in anismus and Parkinson\u2019s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry. 1988;51:1503\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"655_CR122","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord. 2004;19:1306\u201312. doi: 10.1002\/mds.20153 .","journal-title":"Mov Disord"},{"key":"655_CR123","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0016-5085(51)80183-5","volume":"17","author":"A Lewitan","year":"1951","unstructured":"Lewitan A, Nathanson L, Slade Jr WR. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology. 1951;17:367\u201374.","journal-title":"Gastroenterology"},{"key":"655_CR124","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/85.1.73","volume":"85","author":"LH Caplan","year":"1965","unstructured":"Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ. Megacolon and volvulus in Parkinson\u2019s disease. Radiology. 1965;85:73\u20139. doi: 10.1148\/85.1.73 .","journal-title":"Radiology"},{"key":"655_CR125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1838(81)90059-X","volume":"3","author":"WC Groat de","year":"1981","unstructured":"de Groat WC, Nadelhaft I, Milne RJ, Booth AM, Morgan C, Thor K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst. 1981;3:135\u201360.","journal-title":"J Auton Nerv Syst"},{"key":"655_CR126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0079-6123(05)52022-3","volume":"152","author":"AC Lynch","year":"2006","unstructured":"Lynch AC, Frizelle FA. Colorectal motility and defecation after spinal cord injury in humans. Prog Brain Res. 2006;152:335\u201343. doi: 10.1016\/S0079-6123(05)52022-3 .","journal-title":"Prog Brain Res"},{"key":"655_CR127","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1468-1331.2009.02788.x","volume":"17","author":"C Rodriguez-Blazquez","year":"2010","unstructured":"Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P, Longitudinal Parkinson\u2019s Disease Patient Study ELdPcEdPG. Independent validation of the scales for outcomes in Parkinson\u2019s disease-autonomic (SCOPA-AUT). Eur J Neurol. 2010;17:194\u2013201. doi: 10.1111\/j.1468-1331.2009.02788.x .","journal-title":"Eur J Neurol"},{"key":"655_CR128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870060211","volume":"6","author":"LL Edwards","year":"1991","unstructured":"Edwards LL, Pfeiffer RF, Quigley EM, Hofman R, Balluff M. Gastrointestinal symptoms in Parkinson\u2019s disease. Mov Disord. 1991;6:151\u20136. doi: 10.1002\/mds.870060211 .","journal-title":"Mov Disord"},{"key":"655_CR129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2340\/16501977-0456","volume":"41","author":"CM Chiu","year":"2009","unstructured":"Chiu CM, Wang CP, Sung WH, Huang SF, Chiang SC, Tsai PY. Functional magnetic stimulation in constipation associated with Parkinson\u2019s disease. J Rehabil Med. 2009;41:1085\u20139. doi: 10.2340\/16501977-0456 .","journal-title":"J Rehabil Med"},{"key":"655_CR130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","volume":"22","author":"F Cadeddu","year":"2005","unstructured":"Cadeddu F, Bentivoglio AR, Brandara F, Marniga G, Brisinda G, Maria G. Outlet type constipation in Parkinson\u2019s disease: results of botulinum toxin treatment. Aliment Pharmacol Ther. 2005;22:997\u20131003. doi: 10.1111\/j.1365-2036.2005.02669.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"655_CR131","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30:1600\u201311. doi: 10.1002\/mds.26431 .","journal-title":"Mov Disord"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-016-0655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-016-0655-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-016-0655-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:12:53Z","timestamp":1567789973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-016-0655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s11910-016-0655-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"article-number":"51"}}